Related Experiment Videos
Postimplantation development of mitomycin C-treated mouse blastocysts
1Department of Anatomy, Faculty of Medicine, Chinese University of Hong Kong, Shatin.
Abstract:
Treatment of morula-stage mouse embryos with mitomycin C (0.004-0.5 microgram/ml) in vitro resulted in a decrease in the number of inner cell mass (ICM) cells at the blastocyst stage. The trophectoderm population was reduced only at the highest dosage (0.5 microgram/ml) tested. Postblastocyst development in vitro was retarded: Fewer embryos formed trophoblastic outgrowth, and the ICM was poorly developed. The embryo transfer experiments demonstrated that a reduction in ICM cell numbers diminished the potential of embryogenesis. The presence of a sufficient number of trophoblasts and ICM cells in the blastocyst is therefore a prerequisite for successful implantation and embryogenesis. The mitomycin-treated blastocysts with only 70% of normal ICM cells developed to egg cylinders that were about half normal size, but by days 12-14 the body size of the surviving embryo was similar to that of the control embryo. Morphogenesis was retarded during the early organogenesis stages, but only a slight delay was seen in the treated embryo on day 12. Such observation strongly suggests that a restorative phase of growth and morphogenesis has occurred during the immediate postimplantation period.
Insights
Mitomycin C treatment reduced inner cell mass (ICM) cells in mouse embryos, hindering development. Sufficient ICM and trophectoderm cells are crucial for successful embryogenesis and implantation.
Area of Science:
- Developmental Biology
- Embryology
- Toxicology
Background:
- The early development of mammalian embryos is a complex process involving precise cell differentiation and proliferation.
- The inner cell mass (ICM) and trophectoderm are critical cell populations within the blastocyst, giving rise to the embryo proper and extraembryonic tissues, respectively.
Purpose of the Study:
- To investigate the effects of mitomycin C, a DNA-crosslinking agent, on early mouse embryo development.
- To determine the impact of reduced inner cell mass (ICM) cell numbers on subsequent embryogenesis and postimplantation development.
Main Methods:
- Morula-stage mouse embryos were cultured in vitro with varying concentrations of mitomycin C.
- Blastocyst development was assessed by counting ICM and trophectoderm cells.
- Embryo transfer experiments were conducted to evaluate postimplantation development.
Main Results:
- Mitomycin C treatment decreased ICM cell numbers in a dose-dependent manner, with effects on trophectoderm only at the highest dose.
- Postblastocyst development in vitro was impaired, with reduced trophoblastic outgrowth and poor ICM development.
- Embryo transfer revealed that reduced ICM cell numbers significantly diminished embryogenesis potential, though some recovery was observed postimplantation.
Conclusions:
- A sufficient number of ICM and trophectoderm cells in the blastocyst is essential for successful implantation and embryogenesis.
- While mitomycin C can disrupt early development, mouse embryos exhibit a restorative capacity during the postimplantation period.